Literature DB >> 2314743

Prader-Willi syndrome in New Zealand: a survey of 36 affected people.

L Thornton1, K P Dawson.   

Abstract

The Prader-Willi syndrome consists of infantile hypotonia, failure to thrive, hypogonadism and developmental delay. It was first described in 1956. Later in life hypotonia improves. Between the age of two and four obesity becomes noticeable and between six and ten there is uncontrollable behaviour. A survey has been carried out of the 36 known cases in New Zealand and the pattern of the disease is similar to that elsewhere. In most cases the diagnosis was not established until between the ages of six and 10 when the obesity was marked and uncontrolled behaviour a problem. Early control of the obesity is helpful.

Entities:  

Mesh:

Year:  1990        PMID: 2314743

Source DB:  PubMed          Journal:  N Z Med J        ISSN: 0028-8446


  6 in total

1.  Social escape behaviors in children with fragile X syndrome.

Authors:  Scott Hall; Marie DeBernardis; Allan Reiss
Journal:  J Autism Dev Disord       Date:  2006-10

2.  Self-injurious behavior and Prader-Willi syndrome: behavioral forms and body locations.

Authors:  F J Symons; M G Butler; M D Sanders; I D Feurer; T Thompson
Journal:  Am J Ment Retard       Date:  1999-05

3.  A preliminary analysis of the phenomenology of skin-picking in Prader-Willi syndrome.

Authors:  Jessica R Morgan; Eric A Storch; Douglas W Woods; Danielle Bodzin; Adam B Lewin; Tanya K Murphy
Journal:  Child Psychiatry Hum Dev       Date:  2010-08

4.  Modeling family dynamics in children with fragile x syndrome.

Authors:  Scott S Hall; David D Burns; Allan L Reiss
Journal:  J Abnorm Child Psychol       Date:  2007-02

5.  Prader-Willi Syndrome: Clinical and Genetic Findings.

Authors:  Merlin G Butler; Travis Thompson
Journal:  Endocrinologist       Date:  2000-07

Review 6.  The RDoC approach for translational psychiatry: Could a genetic disorder with psychiatric symptoms help fill the matrix? the example of Prader-Willi syndrome.

Authors:  Juliette Salles; Emmanuelle Lacassagne; Grégoire Benvegnu; Sophie Çabal Berthoumieu; Nicolas Franchitto; Maithé Tauber
Journal:  Transl Psychiatry       Date:  2020-08-08       Impact factor: 6.222

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.